Jayson Bedford
Stock Analyst at Raymond James
(4.02)
# 453
Out of 4,827 analysts
309
Total ratings
56.51%
Success rate
7.72%
Average return
Main Sectors:
Stocks Rated by Jayson Bedford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MASI Masimo | Maintains: Outperform | $204 → $185 | $153.80 | +20.29% | 7 | May 7, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $119 → $104 | $94.40 | +10.17% | 8 | May 6, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $116 → $108 | $94.93 | +13.77% | 27 | Apr 25, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $132 → $142 | $133.81 | +6.12% | 28 | Apr 17, 2025 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $162 → $164 | $156.22 | +4.98% | 23 | Apr 16, 2025 | |
| PODD Insulet | Reiterates: Outperform | $294 → $328 | $265.34 | +23.61% | 26 | Feb 21, 2025 | |
| BSX Boston Scientific | Maintains: Strong Buy | $119 → $122 | $104.28 | +17.00% | 24 | Feb 6, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $560 → $688 | $539.22 | +27.59% | 8 | Jan 24, 2025 | |
| DXCM DexCom | Maintains: Strong Buy | $115 → $99 | $84.53 | +17.12% | 30 | Oct 25, 2024 | |
| ICUI ICU Medical | Maintains: Outperform | $158 → $190 | $140.65 | +35.08% | 19 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $270 | $167.86 | +60.85% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $12.21 | +6.47% | 1 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $10 | $9.13 | +9.59% | 14 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $227 → $271 | $125.26 | +116.35% | 12 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $8.91 | - | 10 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $22.56 | - | 13 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $75.55 | - | 20 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $31.44 | - | 6 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $83.68 | - | 14 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $0.70 | - | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $86 | $54.96 | +56.48% | 4 | Nov 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.86 | - | 5 | Aug 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $13.03 | - | 3 | Jan 2, 2018 |
Masimo
May 7, 2025
Maintains: Outperform
Price Target: $204 → $185
Current: $153.80
Upside: +20.29%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Outperform
Price Target: $119 → $104
Current: $94.40
Upside: +10.17%
Merit Medical Systems
Apr 25, 2025
Maintains: Outperform
Price Target: $116 → $108
Current: $94.93
Upside: +13.77%
Abbott Laboratories
Apr 17, 2025
Maintains: Outperform
Price Target: $132 → $142
Current: $133.81
Upside: +6.12%
Johnson & Johnson
Apr 16, 2025
Maintains: Outperform
Price Target: $162 → $164
Current: $156.22
Upside: +4.98%
Insulet
Feb 21, 2025
Reiterates: Outperform
Price Target: $294 → $328
Current: $265.34
Upside: +23.61%
Boston Scientific
Feb 6, 2025
Maintains: Strong Buy
Price Target: $119 → $122
Current: $104.28
Upside: +17.00%
Intuitive Surgical
Jan 24, 2025
Maintains: Outperform
Price Target: $560 → $688
Current: $539.22
Upside: +27.59%
DexCom
Oct 25, 2024
Maintains: Strong Buy
Price Target: $115 → $99
Current: $84.53
Upside: +17.12%
ICU Medical
Sep 12, 2024
Maintains: Outperform
Price Target: $158 → $190
Current: $140.65
Upside: +35.08%
Aug 2, 2024
Maintains: Outperform
Price Target: $275 → $270
Current: $167.86
Upside: +60.85%
Jul 1, 2024
Initiates: Outperform
Price Target: $13
Current: $12.21
Upside: +6.47%
Jan 9, 2024
Maintains: Outperform
Price Target: $12 → $10
Current: $9.13
Upside: +9.59%
Dec 20, 2023
Maintains: Outperform
Price Target: $227 → $271
Current: $125.26
Upside: +116.35%
Nov 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $8.91
Upside: -
Apr 24, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $22.56
Upside: -
Feb 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $75.55
Upside: -
Jan 5, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $31.44
Upside: -
Aug 24, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $83.68
Upside: -
Mar 5, 2021
Downgrades: Underperform
Price Target: n/a
Current: $0.70
Upside: -
Nov 5, 2020
Maintains: Outperform
Price Target: $75 → $86
Current: $54.96
Upside: +56.48%
Aug 2, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $1.86
Upside: -
Jan 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $13.03
Upside: -